Growth Metrics

Item 9 Labs (INLB) Shares Outstanding (2016 - 2023)

Item 9 Labs' Shares Outstanding history spans 13 years, with the latest figure at -$12.3 million for Q2 2023.

  • For Q2 2023, Shares Outstanding fell 111.33% year-over-year to -$12.3 million; the TTM value through Jun 2023 reached -$12.3 million, down 111.33%, while the annual FY2022 figure was $97.7 million, 8.8% down from the prior year.
  • Shares Outstanding reached $114.7 million in Q2 2023 per INLB's latest filing, up from $114.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $114.7 million in Q2 2023 to a low of -$12.3 million in Q3 2021.
  • Average Shares Outstanding over 5 years is $55.2 million, with a median of $63.6 million recorded in 2019.
  • Peak YoY movement for Shares Outstanding: plummeted 111.81% in 2022, then soared 1026.73% in 2023.
  • A 5-year view of Shares Outstanding shows it stood at $63.7 million in 2019, then increased by 18.1% to $75.3 million in 2020, then skyrocketed by 42.5% to $107.2 million in 2021, then grew by 4.72% to $112.3 million in 2022, then crashed by 110.95% to -$12.3 million in 2023.
  • Per Business Quant, the three most recent readings for INLB's Shares Outstanding are -$12.3 million (Q2 2023), $114.0 million (Q1 2023), and $112.3 million (Q4 2022).